Piramal Pharma Revenue

In the fiscal year ending March 31, 2025, Piramal Pharma had annual revenue of 92.86B INR with 13.64% growth. Piramal Pharma had revenue of 27.96B in the quarter ending March 31, 2025, with 9.55% growth.

Revenue

92.86B

Revenue Growth

+13.64%

P/S Ratio

3.13

Revenue / Employee

13.82M

Employees

6,719

Market Cap

290.39B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	92.86B	11.15B	13.64%
Mar 31, 2024	81.71B	10.90B	15.39%
Mar 31, 2023	70.82B	3.47B	5.16%
Mar 31, 2022	67.34B	8.47B	14.39%
Mar 31, 2021	58.87B	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sun Pharmaceutical Industries	516.03B
Divi's Laboratories	90.78B
Cipla	267.20B
Mankind Pharma	116.41B
Apollo Hospitals Enterprise	211.46B
Zydus Lifesciences	222.47B
Aurobindo Pharma	309.22B
Alkem Laboratories	127.57B

Revenue Rankings